All roads lead back to China,” declares Dealmed CEO Michael Einhorn of his company’s journey to remake its supply chain.

Beijing has continued to welcome U.S.-made medical supplies despite a drive for economic independence.

Mayur Maheshwari, CEO of UPSIDA, said the Bulk Drug Pharma Park would be important in reducing India's dependence on China ...

Xiangxiang Ma, a partner of Anjie Broad Law Firm, explores the various ways in which a recent U.S. executive order on drug pricing is impacting Chinese pharmaceutical companies’ license-out model ...

U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. Recent deals could be worth ...

HIS ASEAN 2025 to make its debut in Kuala Lumpur between June 9 and 11 to discuss Southeast Asia’s medical innovation surge: Our Bureau, Mumbai Friday, June 6, 2025, 14:30 Hrs ...

Federal Express Corporation, one of the world’s largest express transportation companies, announced today that its hubs at ...

China has leaped from fast follower to global pioneer in drug discovery and development. We believe that Chinese companies ...

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

The small-cap stock in the specialty chemical sector is anticipated to draw attention to Sudarshan Pharma Industries Limiteds ...

TOKYO, JAPAN - Media OutReach Newswire - 3 June 2025 - Bensang Pharmaceuticals (China), a leading health and wellness brand, ...

Asian equities were mostly higher overnight as Korea and Taiwan outperformed while the Philippines and Thailand ...